Global Monoclonal Antibodies Market To Set At CAGR Of 9.84% Between 2016-2020

The Report Global Monoclonal Antibodies Market 2016-2020 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

About Monoclonal Antibodies

Antibodies are the proteins produced by B-cells (in the bone marrow) in the immune system. These proteins attach themselves to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies, which attach themselves to different sites of an antigen. mAbs are monospecific, as they are the clones of a single parent cell. They are complex proteins with high molecular weight, and were first developed in 1975 by Kohler and Milstein.

Technavios analysts forecast the global monoclonal antibodies (mAbs) market to grow at a CAGR of 9.84% during the period 2016-2020.

View Report At :

Covered in this report

The report covers the present scenario and the growth prospects of the global monoclonal antibodies (mAbs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded mAbs and biosimilars used to treat cancer, autoimmune and inflammatory diseases, respiratory diseases, and ophthalmology. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market, along with the decline in revenues from the patent expiries of the marketed drugs, during the forecast period.

The market is divided into the following segments based on geography:




Technavio’s report, Global Monoclonal Antibodies (mAbs) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Download Sample copy of this Report at:

Key vendors



Bristol-Myers Squibb

F. Hoffmann-La Roche

Johnson & Johnson


Other prominent vendors


ADC Therapeutics


Alexion Pharmaceuticals



Astellas Pharma

Human Genome Sciences





Seattle Genetics




Market driver

Special regulatory drug designations

For a full, detailed list, view our report

Market challenge

High manufacturing costs coupled with stringent regulations

For a full, detailed list, view our report

Market trend

Growing focus of vendors on untapped markets

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Follow us on LinkedIn:

Table Of Content

PART 01: Executive summary


PART 02: Scope of the report

Market overview


Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: mAbs: Overview

Evolution of mAb therapeutics

Types of mAbs

Conjugated cancer therapies using mAbs

PART 06: Market landscape

Market overview

Five forces analysis

PART 07: Market segmentation by type of mAbs

Naked mAbs

Conjugated mAbs

PART 08: Market segmentation by application

Global oncology mAbs market

Global autoimmune and inflammatory mAbs market

TNF inhibitors

IL-1 blockers

PDE4 inhibitors

Global respiratory mAbs market

Global ophthalmology mAbs market

PART 09: Geographical segmentation

Global mAbs market by geographical segmentation 2015-2020

mAbs market in Americas

mAbs market in US

mAbs market in EMEA

mAbs market in APAC

PART 10: Key leading countries

PART 11: Pipeline portfolio

PART 12: Market drivers

Reimbursement benefits for mAbs and its biosimilars

Special regulatory drug designations

Increase in demand for ADCs

Increase in industry-academia collaborations

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074



Designed by
Powered by